A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1  

作　　者：Haisheng Yu Pengle Guo Yingyin Yang Jun Dai Xiaoping Tang Linghua Li 

机构地区：[1]Guangzhou Eighth People’s Hospital,Guangzhou Medical University,Guangzhou,Guangdong 510440,China

出　　处：《Chinese Medical Journal》2023年第18期2243-2245,共3页中华医学杂志（英文版）

基　　金：Key R&D Program of Guangdong Province(No.2021A1111110002);Guangzhou Basic Research Program on People’s Livelihood Science and Technology(No.202002020005);National Natural Science Foundation of China(No.82072265)

摘　　要：To the Editor:Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)is the virus that caused the 2019 coronavirus disease(COVID-19)pandemic.Over two years after the initial outbreak,several more infectious variations of the virus continue to pose a grave threat to global public health.[1]Intense,worldwide efforts for vaccine development have led to several candidate vaccines utilizing a variety of platforms.

关 键 词：VACCINE ACUTE RESPIRATORY 

分 类 号：R512.91[医药卫生—内科学] R186[医药卫生—临床医学]